Lazard Ltd. (LAZ) Tops Q3 EPS by 26c

Lazard Ltd. (NYSE: LAZ) reported Q3 EPS of $1.05, $0.26 better than the analyst estimate of $0.79. Revenue for the quarter came in at $746.43 million versus the consensus estimate of $644.58 million.

For earnings history and earnings-related data on Lazard Ltd. (LAZ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c